PMID- 34796093 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220428 IS - 2230-5254 (Electronic) IS - 2230-5254 (Linking) VI - 10 DP - 2021 TI - Clinical Pharmacist's Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan. PG - 135-143 LID - 10.2147/IPRP.S341621 [doi] AB - BACKGROUND: Medications known to improve outcomes in heart failure (HF) are either not prescribed or prescribed at sub-therapeutic doses. The addition of clinical pharmacists to the HF team positively impacts optimizing prognostic medications for a patient with HF with reduced ejection fraction (HFrEF). OBJECTIVE: To assess the intervention of the clinical pharmacist as part of the multidisciplinary (MD) team in up-titration to achieve target doses of key therapeutic agents for HFrEF. METHODS: This was a prospective one group pretest-posttest interventional study; a comparison of the target dose achievement of key therapeutic agents for HFrEF was performed before and after clinical pharmacist interventions. RESULTS: Out of 110 HFrEF patients, 57.3% were males, and the mean age of patients was 55.8 years (SD 12.6). Cardiomyopathy was the leading cause of HF. At baseline, 86% were on angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor-neprilysin inhibitors (ACEIs/ARBs/ARNi) and 93.6% on beta blockers (BBs). At the end of study, the proportion of patients achieved the target dose was significantly increased (0 vs 77.4%, 6.8 vs 85.4%, and 0 vs 55.6%) for ACEIs, ARBs and ARNi, respectively, and (8.6% vs 66.1%; P = 0.001) for BBs. Moreover, the up-titration process was associated with significant improvement in most clinical as ejection fraction and New York Heart Association (NYHA) scale and laboratory characteristics. CONCLUSION: As a part of the MD team in the outpatient HF clinic, the clinical pharmacists increased the percentage of HFrEF patients achieving the target or maximal doses of key therapeutic agents and improving clinical and laboratory parameters. CI - (c) 2021 Ahmed et al. FAU - Ahmed, Kannan O AU - Ahmed KO AD - Department of Clinical Pharmacy, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan. FAU - Taj Eldin, Imad AU - Taj Eldin I AD - Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan. FAU - Yousif, Mirghani AU - Yousif M AD - Department of Clinical Pharmacy, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan. FAU - Albarraq, Ahmed A AU - Albarraq AA AD - Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia. FAU - Yousef, Bashir A AU - Yousef BA AUID- ORCID: 0000-0001-7832-4556 AD - Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan. FAU - Ahmed, Nasrein AU - Ahmed N AD - Department of Cardiology, Ahmed Gasim Cardiac Surgery and Renal Transplantation Centre, Khartoum, Sudan. FAU - Babiker, Anas AU - Babiker A AD - Department of Cardiology, Royal Care International Hospital, Khartoum, Sudan. LA - eng PT - Journal Article DEP - 20211111 PL - New Zealand TA - Integr Pharm Res Pract JT - Integrated pharmacy research & practice JID - 101656778 PMC - PMC8593340 OTO - NOTNLM OT - Sudan OT - clinical pharmacist OT - heart failure OT - intervention OT - medications titration COIS- The authors declare that they have no conflicts of interest for this work. EDAT- 2021/11/20 06:00 MHDA- 2021/11/20 06:01 PMCR- 2021/11/11 CRDT- 2021/11/19 06:58 PHST- 2021/09/27 00:00 [received] PHST- 2021/11/05 00:00 [accepted] PHST- 2021/11/19 06:58 [entrez] PHST- 2021/11/20 06:00 [pubmed] PHST- 2021/11/20 06:01 [medline] PHST- 2021/11/11 00:00 [pmc-release] AID - 341621 [pii] AID - 10.2147/IPRP.S341621 [doi] PST - epublish SO - Integr Pharm Res Pract. 2021 Nov 11;10:135-143. doi: 10.2147/IPRP.S341621. eCollection 2021.